Haleos Labs Limi

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE320X01016
  • NSEID: HALEOSLABS
  • BSEID: 540679
INR
1,335.00
19.9 (1.51%)
BSENSE

Dec 05

BSE+NSE Vol: 362

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
81.37
82.50
89.11
84.60
78.46
92.55
89.99
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
81.37
82.50
89.11
84.60
78.46
92.55
89.99
Raw Material Cost
39.83
28.41
32.74
39.43
35.01
42.72
33.47
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-8.81
6.73
6.63
-3.84
0.76
0.60
10.32
Employee Cost
16.23
16.29
16.47
14.60
14.09
14.38
13.49
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
17.32
16.50
16.95
17.58
14.70
16.33
16.32
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
3.22
2.86
8.90
4.07
5.34
2.23
5.03
Total Expenditure (Excl Depreciation)
67.79
70.79
81.69
71.84
69.90
76.26
78.63
Operating Profit (PBDIT) excl Other Income
13.58
11.71
7.42
12.76
8.56
16.29
11.36
Other Income
0.42
1.00
2.34
0.06
2.04
0.44
2.36
Operating Profit (PBDIT)
14.00
12.71
9.76
12.82
10.60
16.73
13.72
Interest
1.62
1.87
2.03
2.14
2.14
2.40
2.84
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
12.38
10.84
7.73
10.68
8.46
14.33
10.88
Depreciation
3.89
3.82
3.80
3.76
3.76
3.68
3.78
Profit Before Tax
8.49
7.02
3.93
6.92
4.70
10.64
7.10
Tax
2.07
2.64
0.45
2.06
1.40
3.54
0.63
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
6.43
4.38
3.48
4.85
3.30
7.10
6.47
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
6.43
4.38
3.48
4.85
3.30
7.10
6.47
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.32
0.23
0.51
-0.61
-1.37
0.10
0.57
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
6.10
4.16
2.97
5.47
4.67
7.00
5.90
Equity Capital
3.02
3.02
3.02
3.02
3.02
3.02
3.02
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
20.2
13.77
9.83
18.11
15.46
23.18
19.54
Diluted Earnings per share
20.19
13.75
9.83
18.08
15.46
23.15
19.53
Operating Profit Margin (Excl OI)
16.69%
14.19%
8.33%
15.08%
10.91%
17.6%
12.62%
Gross Profit Margin
15.21%
13.14%
8.67%
12.62%
10.78%
15.48%
12.09%
PAT Margin
7.9%
5.31%
3.91%
5.73%
4.21%
7.67%
7.19%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Sep 2025 is 3.71% vs 13.28% in Sep 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Sep 2025 is 30.62% vs 586.76% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2025 is 58.64% vs 8.08% in Sep 2024

stock-summary

Interest

YoY Growth in quarter ended Sep 2025 is -24.30% vs -23.84% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024

Compare Quarterly Results Of Haleos Labs Limi With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
81.37
34.84
46.53
133.55%
Other Operating Income
0.00
0.00
0.00
Total Operating income
81.37
34.84
46.53
133.55%
Raw Material Cost
39.83
11.16
28.67
256.90%
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
-8.81
-1.04
-7.77
-747.12%
Employee Cost
16.23
15.84
0.39
2.46%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
17.32
0.00
17.32
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
3.22
13.83
-10.61
-76.72%
Total Expenditure (Excl Depreciation)
67.79
39.79
28.00
70.37%
Operating Profit (PBDIT) excl Other Income
13.58
-4.95
18.53
374.34%
Other Income
0.42
1.70
-1.28
-75.29%
Operating Profit (PBDIT)
14.00
-3.25
17.25
530.77%
Interest
1.62
2.58
-0.96
-37.21%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
12.38
-5.83
18.21
312.35%
Depreciation
3.89
0.99
2.90
292.93%
Profit Before Tax
8.49
-6.82
15.31
224.49%
Tax
2.07
-0.46
2.53
550.00%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
6.43
-6.36
12.79
201.10%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
6.43
-6.36
12.79
201.10%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.32
-0.02
0.34
1,700.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
6.10
-6.34
12.44
196.21%
Equity Capital
3.02
12.06
-9.04
-74.96%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
20.20
-5.26
25.46
484.03%
Diluted Earnings per share
20.19
-7.23
27.42
379.25%
Operating Profit Margin (Excl OI)
16.69%
-14.21%
0.00
30.90%
Gross Profit Margin
15.21%
-16.73%
0.00
31.94%
PAT Margin
7.90%
-18.25%
0.00
26.15%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 81.37 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is -1.37% vs -7.42% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 3.71% vs 13.28% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 6.10 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 46.63% vs 40.07% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 30.62% vs 586.76% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 13.58 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 15.97% vs 57.82% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 58.64% vs 8.08% in Sep 2024

Quarterly - Interest
Interest 1.62 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is -13.37% vs -7.88% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -24.30% vs -23.84% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.69%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024